Criteria Bio Ventures

Criteria Bio Ventures is a leading life sciences venture fund looking to partner with transformative companies to shape the future of healthcare.

[Criteria Bio Ventures @CriteriaBioVC]

Pleased to have participated in the oversubscribed $17.2M seed financing of Tolerance Bio, a Philadelphia based #biopharma pioneering thymus-based therapies for immune-mediated diseases.

News here: https://t.co/aNHjz2kt8N

#portfolionews #venturecapital #biotech #immunology

[Criteria Bio Ventures @CriteriaBioVC]

@sanofi @Amgen Proud to welcome Tolerance Bio to our portfolio and support its innovative programs in the exciting field of thymus-based therapies!

Learn more about Tolerance Bio & this financing: https://t.co/aNHjz2kt8N

#portfolionews #venturecapital #lifesciences #financing #autoimmunity

[Criteria Bio Ventures @CriteriaBioVC]

Pleased to have participated in the oversubscribed $17.2M seed financing of Tolerance Bio, a Philadelphia based #biopharma pioneering thymus-based therapies for immune-mediated diseases.

News here: https://t.co/aNHjz2kt8N

#portfolionews #venturecapital #biotech #immunology

[Criteria Bio Ventures @CriteriaBioVC]

@sanofi @Amgen Tolerance Bio is developing an allogeneic, or “off the shelf”, thymus iPSC-based #celltherapy platform along w pharmacological thymus therapies to address immune-mediated diseases caused by abnormalities in immune tolerance like autoimmune diseases, transplant rejection & cancer

[Criteria Bio Ventures @CriteriaBioVC]

Proud sponsors one more edition of @CataloniaBioHT #BBQ2024. See you all next week at one of the best #biotech summer events in town!

[Catalonia.Health @CataloniaHealth]

🟢 Hurry up! The #BBQ2024 is back next week and there are very few tickets available! 😎

👉 https://t.co/GjS0r2ZAZ3

🙌 Our sponsors:
🥇/deeplabs, @leanbiopro, @GPPharm, @YsiosCapital
🥈@AsabysPartners, @Asphalion, @CriteriaBioVC , @inveready, @InvivoCapital @merckgroup

[ASEICA @ASEICAnews]

📢Pablo Cironi (@CriteriaBioVC) resume los highlights de su intervención y el papel de Caixa Capital Risk

📍Taller 'Introducción a la Innovación y Transferencia en Biomedicina y Salud' de ASEICA-@FundlaCaixa @msmelanoma 

ℹ️:https://t.co/ZGRiLRYpAn

[Criteria Bio Ventures @CriteriaBioVC]

We are attending @AseBio Investor Day!

A fantastic event to feel the pulse of the Spanish biotech ecosystem.

#AseBioID2024

[Criteria Bio Ventures @CriteriaBioVC]

Next week we will be attending #BioEquityEurope 2024 in San Sebastian to meet #biotech entrepreneurs and catch up with #pharma industry leaders and fellow #venturecapital investors.

If you are also participating, get in touch with us to arrange a meet up! 🤝

[Criteria Bio Ventures @CriteriaBioVC]

Today we attended the second edition of @CataloniaBioHT #ConnectionDay24

[Catalonia.Health @CataloniaHealth]

🔛🟢 The second edition of the #ConnectionDay24 is on!

Many thanks to all attendees for your trust and for having exceeded expectations, once again, this year. Let networking and connections begin!

#WeAreCataloniaBioHT

[Criteria Bio Ventures @CriteriaBioVC]

Next week we will be attending #BIOEuropeSpring 2024 in Barcelona to meet #biotech entrepreneurs and catch up with #pharma industry leaders and fellow #venturecapital investors.

If you are also participating, get in touch with us to arrange a meet up! 🤝

[Criteria Bio Ventures @CriteriaBioVC]

Thrilled to announce the well-deserved promotions of @RubenSebas_ and Salvatore Cappadona to Senior Associates within our investment team 🚀

Their exceptional talent and invaluable contributions have been instrumental in driving our mission forward. Congrats Ruben & Salvatore!

[Criteria Bio Ventures @CriteriaBioVC]

Today Pablo Cironi, Managing Director, and @RubenSebas_, Sr Associate, are representing @CriteriaBioVC at CNIO Investor's Day 2024.

A great event to interact with the scientists of one of the leading cancer research centers worldwide.

@CNIOStopCancer
#cancertherapy #innovation

[Criteria Bio Ventures @CriteriaBioVC]

Our portfolio company @Inbiomotion and @SourceBio have signed an exclusive agreement for MAF Test® in the UK and Ireland.

The MAF Test® will benefit ~56,000 new #breastcancer patients each year.

More info 👉 https://t.co/PGwMRhaa2x

#CBVnews #portfolionews #oncology

[Criteria Bio Ventures @CriteriaBioVC]

#tbt last year we welcomed AbolerIS Pharma! We led the €27.3M Series A round of AbolerIS, a Belgian #biotech developing a novel immunotherapy for autoimmune and inflammatory diseases.

#CBVnews #portfolionews #immunology #autoimmunity #venturecapital
https://t.co/AHOGrkWOOy

[Caixa Capital Risc @CaixaCR]

Meet the @CriteriaBioVC team! Stay informed about the latest news from our portfolio. Follow us on this new account for updates on our #biotech and #lifesciences investments and team activities!
@CriteriaBioVC web➡️ https://t.co/QpPaqykoGT
#biotech #lifesciences #pharma

[Caixa Capital Risc @CaixaCR]

We are launching new @X profiles! From today we will share our #VC activity on #Tech topics from the account @CriteriaVT. Everything related to #Biotech and #LifeSciences will be available at @CriteriaBioVC.
Follow us ⬇️!
🔬https://t.co/QpPaqykoGT
🤖https://t.co/WbmbjgN72i

[Criteria Bio Ventures @CriteriaBioVC]

Exciting news! Our new website is live, providing a fresh look into Criteria Bio Ventures. Follow us for updates on our portfolio, team activities, and more.
Let the journey begin! 🚀
#CBVnews #venturecapital #biotech #lifesciences #pharma
https://t.co/MV7pBNuP7p